Rank | Gene Set | Z-score |
---|---|---|
1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.90410149 |
2 | L-phenylalanine catabolic process (GO:0006559) | 6.90410149 |
3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.76853997 |
4 | L-phenylalanine metabolic process (GO:0006558) | 6.76853997 |
5 | aromatic amino acid family catabolic process (GO:0009074) | 6.33290342 |
6 | indole-containing compound catabolic process (GO:0042436) | 5.87801186 |
7 | indolalkylamine catabolic process (GO:0046218) | 5.87801186 |
8 | tryptophan catabolic process (GO:0006569) | 5.87801186 |
9 | daunorubicin metabolic process (GO:0044597) | 5.83945337 |
10 | polyketide metabolic process (GO:0030638) | 5.83945337 |
11 | doxorubicin metabolic process (GO:0044598) | 5.83945337 |
12 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.79533162 |
13 | negative regulation of fibrinolysis (GO:0051918) | 5.73749834 |
14 | bile acid biosynthetic process (GO:0006699) | 5.69784694 |
15 | urea cycle (GO:0000050) | 5.60582460 |
16 | urea metabolic process (GO:0019627) | 5.60582460 |
17 | kynurenine metabolic process (GO:0070189) | 5.60302769 |
18 | regulation of fibrinolysis (GO:0051917) | 5.45727876 |
19 | tryptophan metabolic process (GO:0006568) | 5.44710956 |
20 | cellular glucuronidation (GO:0052695) | 5.31030165 |
21 | sulfur amino acid catabolic process (GO:0000098) | 5.26798835 |
22 | glyoxylate metabolic process (GO:0046487) | 5.26540881 |
23 | complement activation, alternative pathway (GO:0006957) | 5.21440355 |
24 | aminoglycoside antibiotic metabolic process (GO:0030647) | 5.19441848 |
25 | regulation of protein activation cascade (GO:2000257) | 5.17102617 |
26 | nitrogen cycle metabolic process (GO:0071941) | 5.15304399 |
27 | protein carboxylation (GO:0018214) | 5.11021520 |
28 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.11021520 |
29 | high-density lipoprotein particle remodeling (GO:0034375) | 5.04043964 |
30 | uronic acid metabolic process (GO:0006063) | 5.01922524 |
31 | glucuronate metabolic process (GO:0019585) | 5.01922524 |
32 | serine family amino acid catabolic process (GO:0009071) | 4.99858307 |
33 | alpha-linolenic acid metabolic process (GO:0036109) | 4.93539685 |
34 | regulation of complement activation (GO:0030449) | 4.89361548 |
35 | cysteine metabolic process (GO:0006534) | 4.89012990 |
36 | phenylpropanoid metabolic process (GO:0009698) | 4.83933122 |
37 | primary alcohol catabolic process (GO:0034310) | 4.81138757 |
38 | bile acid metabolic process (GO:0008206) | 4.75215378 |
39 | epoxygenase P450 pathway (GO:0019373) | 4.72414930 |
40 | regulation of cholesterol esterification (GO:0010872) | 4.67527014 |
41 | aromatic amino acid family metabolic process (GO:0009072) | 4.62949220 |
42 | regulation of triglyceride catabolic process (GO:0010896) | 4.58614037 |
43 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.55614157 |
44 | homocysteine metabolic process (GO:0050667) | 4.49125067 |
45 | reverse cholesterol transport (GO:0043691) | 4.41544068 |
46 | amino-acid betaine metabolic process (GO:0006577) | 4.39213488 |
47 | response to nitrosative stress (GO:0051409) | 4.35092097 |
48 | phospholipid efflux (GO:0033700) | 4.31840644 |
49 | glycine metabolic process (GO:0006544) | 4.31087288 |
50 | benzene-containing compound metabolic process (GO:0042537) | 4.30224667 |
51 | alpha-amino acid catabolic process (GO:1901606) | 4.30128405 |
52 | negative regulation of cholesterol transport (GO:0032375) | 4.29830021 |
53 | negative regulation of sterol transport (GO:0032372) | 4.29830021 |
54 | protein-lipid complex remodeling (GO:0034368) | 4.28757931 |
55 | macromolecular complex remodeling (GO:0034367) | 4.28757931 |
56 | plasma lipoprotein particle remodeling (GO:0034369) | 4.28757931 |
57 | tyrosine metabolic process (GO:0006570) | 4.25619967 |
58 | flavonoid metabolic process (GO:0009812) | 4.23730498 |
59 | triglyceride homeostasis (GO:0070328) | 4.22818868 |
60 | acylglycerol homeostasis (GO:0055090) | 4.22818868 |
61 | drug catabolic process (GO:0042737) | 4.21658069 |
62 | xenobiotic catabolic process (GO:0042178) | 4.17964543 |
63 | ethanol metabolic process (GO:0006067) | 4.17029965 |
64 | bile acid and bile salt transport (GO:0015721) | 4.12732421 |
65 | serine family amino acid metabolic process (GO:0009069) | 4.12359190 |
66 | coenzyme catabolic process (GO:0009109) | 4.11812475 |
67 | cellular modified amino acid catabolic process (GO:0042219) | 4.11697835 |
68 | lysine metabolic process (GO:0006553) | 4.11553191 |
69 | lysine catabolic process (GO:0006554) | 4.11553191 |
70 | fibrinolysis (GO:0042730) | 4.08524852 |
71 | exogenous drug catabolic process (GO:0042738) | 4.06384139 |
72 | amine catabolic process (GO:0009310) | 4.05724246 |
73 | cellular biogenic amine catabolic process (GO:0042402) | 4.05724246 |
74 | cellular amino acid catabolic process (GO:0009063) | 4.03976372 |
75 | arginine metabolic process (GO:0006525) | 4.02737872 |
76 | indolalkylamine metabolic process (GO:0006586) | 4.01860005 |
77 | plasma lipoprotein particle clearance (GO:0034381) | 3.98262332 |
78 | oxidative demethylation (GO:0070989) | 3.97038976 |
79 | aldehyde catabolic process (GO:0046185) | 3.96830170 |
80 | omega-hydroxylase P450 pathway (GO:0097267) | 3.94684537 |
81 | negative regulation of lipase activity (GO:0060192) | 3.87450594 |
82 | cholesterol efflux (GO:0033344) | 3.82781562 |
83 | imidazole-containing compound metabolic process (GO:0052803) | 3.81231234 |
84 | regulation of plasminogen activation (GO:0010755) | 3.80029704 |
85 | regulation of bile acid biosynthetic process (GO:0070857) | 3.76697566 |
86 | ethanol oxidation (GO:0006069) | 3.73152072 |
87 | glutamate metabolic process (GO:0006536) | 3.72703281 |
88 | biotin metabolic process (GO:0006768) | 3.71392193 |
89 | plasma lipoprotein particle assembly (GO:0034377) | 3.70683391 |
90 | serine family amino acid biosynthetic process (GO:0009070) | 3.69610582 |
91 | cofactor catabolic process (GO:0051187) | 3.66635546 |
92 | intestinal cholesterol absorption (GO:0030299) | 3.61017511 |
93 | regulation of cholesterol homeostasis (GO:2000188) | 3.60649484 |
94 | cholesterol homeostasis (GO:0042632) | 3.58804472 |
95 | cytolysis (GO:0019835) | 3.58442242 |
96 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.57775034 |
97 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.57775034 |
98 | carboxylic acid catabolic process (GO:0046395) | 3.57046979 |
99 | organic acid catabolic process (GO:0016054) | 3.57046979 |
100 | blood coagulation, intrinsic pathway (GO:0007597) | 3.55511656 |
101 | phospholipid homeostasis (GO:0055091) | 3.55047641 |
102 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.54551140 |
103 | negative regulation of hemostasis (GO:1900047) | 3.54465376 |
104 | negative regulation of blood coagulation (GO:0030195) | 3.54465376 |
105 | cellular ketone body metabolic process (GO:0046950) | 3.54203080 |
106 | positive regulation of lipid catabolic process (GO:0050996) | 3.53725777 |
107 | complement activation, classical pathway (GO:0006958) | 3.52982819 |
108 | sterol homeostasis (GO:0055092) | 3.52895952 |
109 | drug metabolic process (GO:0017144) | 3.52098099 |
110 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.50497732 |
111 | complement activation (GO:0006956) | 3.49620274 |
112 | protein activation cascade (GO:0072376) | 3.48366280 |
113 | heme transport (GO:0015886) | 3.48154843 |
114 | triglyceride catabolic process (GO:0019433) | 3.44066045 |
115 | low-density lipoprotein particle clearance (GO:0034383) | 3.33283741 |
116 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.30949623 |
117 | acylglycerol catabolic process (GO:0046464) | 3.27494577 |
118 | neutral lipid catabolic process (GO:0046461) | 3.27494577 |
119 | primary alcohol metabolic process (GO:0034308) | 3.26760774 |
120 | acetyl-CoA metabolic process (GO:0006084) | 3.26578931 |
121 | negative regulation of coagulation (GO:0050819) | 3.25460828 |
122 | negative regulation of wound healing (GO:0061045) | 3.21990279 |
123 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.21797031 |
124 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.15924317 |
125 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.12059649 |
126 | drug transmembrane transport (GO:0006855) | 3.01605145 |
127 | retinal metabolic process (GO:0042574) | 3.00849168 |
128 | carnitine metabolic process (GO:0009437) | 2.94210693 |
129 | response to mercury ion (GO:0046689) | 2.93593580 |
130 | negative regulation of protein activation cascade (GO:2000258) | 2.90535405 |
131 | alkaloid metabolic process (GO:0009820) | 2.88628118 |
132 | hormone catabolic process (GO:0042447) | 2.88319935 |
133 | acute-phase response (GO:0006953) | 2.85113370 |
134 | glycoside metabolic process (GO:0016137) | 2.82176780 |
135 | desmosome organization (GO:0002934) | 2.81682942 |
136 | xenobiotic metabolic process (GO:0006805) | 2.81342956 |
137 | negative regulation of fatty acid metabolic process (GO:0045922) | 2.79377650 |
138 | S-adenosylmethionine metabolic process (GO:0046500) | 2.78981807 |
139 | regulation of cholesterol metabolic process (GO:0090181) | 2.76969861 |
140 | very long-chain fatty acid metabolic process (GO:0000038) | 2.74996631 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.00824832 |
2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.80113801 |
3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.50574951 |
4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.10077912 |
5 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.89132765 |
6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.84426662 |
7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.67286060 |
8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.88292767 |
9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.38620031 |
10 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.42729728 |
11 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.30529228 |
12 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.17721260 |
13 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 2.12330593 |
14 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.08792663 |
15 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.02801395 |
16 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.00640741 |
17 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.1791300 |
18 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.99903087 |
19 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.92712118 |
20 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.76657876 |
21 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.67728904 |
22 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.61684583 |
23 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.57860803 |
24 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.44708099 |
25 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.40084007 |
26 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.35656889 |
27 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.35020003 |
28 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.33784139 |
29 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.32557203 |
30 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 1.30792335 |
31 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.28569796 |
32 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.28569796 |
33 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.28030947 |
34 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.27328740 |
35 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.27073834 |
36 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.23869255 |
37 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.22834444 |
38 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.17651279 |
39 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.16372434 |
40 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.12730334 |
41 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.09616539 |
42 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.09015976 |
43 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.05450168 |
44 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.04353907 |
45 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.02254183 |
46 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.01401219 |
47 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.00793216 |
48 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.99930951 |
49 | CJUN_26792858_Chip-Seq_BT549_Human | 0.99558943 |
50 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.99330778 |
51 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.96042369 |
52 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.96042369 |
53 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.95404779 |
54 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.95025949 |
55 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.94197712 |
56 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.93284399 |
57 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.91357987 |
58 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.90822659 |
59 | * SMC4_20622854_ChIP-Seq_HELA_Human | 0.90588849 |
60 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.90233330 |
61 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.88408428 |
62 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.87950178 |
63 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87390972 |
64 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.86554216 |
65 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.86554216 |
66 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.86465972 |
67 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.83641765 |
68 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.83279115 |
69 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.83123565 |
70 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.82978094 |
71 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.81990967 |
72 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.81296212 |
73 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.80819307 |
74 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.80256543 |
75 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.79430534 |
76 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.79108739 |
77 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.79077740 |
78 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.78187882 |
79 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.77080644 |
80 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.75830638 |
81 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.75746977 |
82 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.74764085 |
83 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.74060726 |
84 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.74005355 |
85 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.73830969 |
86 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.73645192 |
87 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.72158222 |
88 | GATA1_22025678_ChIP-Seq_K562_Human | 0.72049126 |
89 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.71817411 |
90 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.71777102 |
91 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.71084088 |
92 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.70729351 |
93 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.68406914 |
94 | * AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.66824451 |
95 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.66334883 |
96 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.65975587 |
97 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.65975587 |
98 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.65975587 |
99 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.65877555 |
100 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.64760776 |
101 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.64685902 |
102 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.64147775 |
103 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.62544025 |
104 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.61021289 |
105 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.60925144 |
106 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.59802125 |
107 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.58744038 |
108 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.58229411 |
109 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.58210159 |
110 | ATF3_27146783_Chip-Seq_COLON_Human | 0.57167080 |
111 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.56490295 |
112 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.55254260 |
113 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.54980736 |
114 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.53494330 |
115 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.53263406 |
116 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.53035245 |
117 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.52318776 |
118 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.52144837 |
119 | * TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.51946770 |
120 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.51234094 |
121 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.50506987 |
122 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.50276938 |
123 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.48873503 |
124 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.48441009 |
125 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.47405654 |
126 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.46600184 |
127 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.46580572 |
128 | AR_20517297_ChIP-Seq_VCAP_Human | 0.46175482 |
129 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.45877338 |
130 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.45836666 |
131 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.45157261 |
132 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.44853143 |
133 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.43846544 |
134 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.43707994 |
135 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.43587567 |
136 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.43179014 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 7.71485105 |
2 | MP0005360_urolithiasis | 6.98438648 |
3 | MP0005085_abnormal_gallbladder_physiolo | 5.96456403 |
4 | MP0005365_abnormal_bile_salt | 5.51371864 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.50961819 |
6 | MP0003806_abnormal_nucleotide_metabolis | 3.81157354 |
7 | MP0003252_abnormal_bile_duct | 3.72081075 |
8 | MP0009840_abnormal_foam_cell | 3.31692144 |
9 | MP0010329_abnormal_lipoprotein_level | 3.18536819 |
10 | MP0005083_abnormal_biliary_tract | 2.71995233 |
11 | MP0005332_abnormal_amino_acid | 2.55903206 |
12 | MP0003195_calcinosis | 2.40583986 |
13 | MP0001666_abnormal_nutrient_absorption | 2.37971112 |
14 | MP0004019_abnormal_vitamin_homeostasis | 2.18418090 |
15 | MP0003705_abnormal_hypodermis_morpholog | 2.05567933 |
16 | MP0003191_abnormal_cellular_cholesterol | 1.98155154 |
17 | MP0003868_abnormal_feces_composition | 1.95235532 |
18 | MP0000609_abnormal_liver_physiology | 1.95144116 |
19 | MP0001661_extended_life_span | 1.89652734 |
20 | MP0002118_abnormal_lipid_homeostasis | 1.79173728 |
21 | MP0005319_abnormal_enzyme/_coenzyme | 1.72009509 |
22 | MP0002138_abnormal_hepatobiliary_system | 1.67911460 |
23 | MP0003186_abnormal_redox_activity | 1.45434295 |
24 | MP0009053_abnormal_anal_canal | 1.39987894 |
25 | MP0009697_abnormal_copulation | 1.38869906 |
26 | MP0010234_abnormal_vibrissa_follicle | 1.35292344 |
27 | MP0003011_delayed_dark_adaptation | 1.33671456 |
28 | MP0005375_adipose_tissue_phenotype | 1.32912455 |
29 | MP0009379_abnormal_foot_pigmentation | 1.32874131 |
30 | MP0000467_abnormal_esophagus_morphology | 1.30379121 |
31 | MP0002098_abnormal_vibrissa_morphology | 1.30203530 |
32 | MP0010368_abnormal_lymphatic_system | 1.28992793 |
33 | MP0001764_abnormal_homeostasis | 1.27816158 |
34 | MP0002254_reproductive_system_inflammat | 1.27245681 |
35 | MP0003941_abnormal_skin_development | 1.24349600 |
36 | MP0008438_abnormal_cutaneous_collagen | 1.23702918 |
37 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.22496465 |
38 | MP0005408_hypopigmentation | 1.21653582 |
39 | MP0005084_abnormal_gallbladder_morpholo | 1.20887223 |
40 | MP0000566_synostosis | 1.18920769 |
41 | MP0005501_abnormal_skin_physiology | 1.18503673 |
42 | MP0000598_abnormal_liver_morphology | 1.16917578 |
43 | MP0005076_abnormal_cell_differentiation | 1.14225948 |
44 | MP0009643_abnormal_urine_homeostasis | 1.13963574 |
45 | MP0002970_abnormal_white_adipose | 1.11732149 |
46 | MP0004185_abnormal_adipocyte_glucose | 1.10903223 |
47 | MP0004264_abnormal_extraembryonic_tissu | 1.10778532 |
48 | MP0005647_abnormal_sex_gland | 1.07970768 |
49 | MP0006138_congestive_heart_failure | 1.04918108 |
50 | MP0009384_cardiac_valve_regurgitation | 1.03467845 |
51 | MP0003656_abnormal_erythrocyte_physiolo | 1.01272706 |
52 | MP0005451_abnormal_body_composition | 1.00017340 |
53 | MP0005670_abnormal_white_adipose | 0.96260650 |
54 | MP0003959_abnormal_lean_body | 0.95762603 |
55 | MP0004130_abnormal_muscle_cell | 0.94673747 |
56 | MP0004858_abnormal_nervous_system | 0.94494254 |
57 | MP0009764_decreased_sensitivity_to | 0.94151218 |
58 | MP0009763_increased_sensitivity_to | 0.93916496 |
59 | MP0000762_abnormal_tongue_morphology | 0.92235917 |
60 | MP0004233_abnormal_muscle_weight | 0.91228065 |
61 | MP0000003_abnormal_adipose_tissue | 0.90074392 |
62 | MP0005248_abnormal_Harderian_gland | 0.88570852 |
63 | MP0003878_abnormal_ear_physiology | 0.87647625 |
64 | MP0005377_hearing/vestibular/ear_phenot | 0.87647625 |
65 | MP0004381_abnormal_hair_follicle | 0.86861889 |
66 | MP0005636_abnormal_mineral_homeostasis | 0.78692698 |
67 | MP0005023_abnormal_wound_healing | 0.78226824 |
68 | MP0010030_abnormal_orbit_morphology | 0.77416743 |
69 | MP0000462_abnormal_digestive_system | 0.76971584 |
70 | MP0005409_darkened_coat_color | 0.76966278 |
71 | MP0001849_ear_inflammation | 0.76059427 |
72 | MP0001881_abnormal_mammary_gland | 0.75521868 |
73 | MP0008469_abnormal_protein_level | 0.74817169 |
74 | MP0000627_abnormal_mammary_gland | 0.73989579 |
75 | MP0009642_abnormal_blood_homeostasis | 0.73799901 |
76 | MP0005275_abnormal_skin_tensile | 0.71758460 |
77 | MP0001216_abnormal_epidermal_layer | 0.71408247 |
78 | MP0009780_abnormal_chondrocyte_physiolo | 0.71182533 |
79 | MP0002249_abnormal_larynx_morphology | 0.71113771 |
80 | MP0002060_abnormal_skin_morphology | 0.70946807 |
81 | MP0005395_other_phenotype | 0.68686466 |
82 | MP0005220_abnormal_exocrine_pancreas | 0.67197966 |
83 | MP0009765_abnormal_xenobiotic_induced | 0.67009070 |
84 | MP0002697_abnormal_eye_size | 0.66614941 |
85 | MP0005376_homeostasis/metabolism_phenot | 0.66391398 |
86 | MP0010771_integument_phenotype | 0.65881505 |
87 | MP0002108_abnormal_muscle_morphology | 0.65593623 |
88 | MP0003279_aneurysm | 0.65234771 |
89 | MP0003724_increased_susceptibility_to | 0.63889354 |
90 | MP0000383_abnormal_hair_follicle | 0.63681156 |
91 | MP0002909_abnormal_adrenal_gland | 0.63346930 |
92 | MP0002089_abnormal_postnatal_growth/wei | 0.61837289 |
93 | MP0003718_maternal_effect | 0.61523477 |
94 | MP0005058_abnormal_lysosome_morphology | 0.61447975 |
95 | MP0005503_abnormal_tendon_morphology | 0.60830506 |
96 | MP0002971_abnormal_brown_adipose | 0.60059443 |
97 | MP0001756_abnormal_urination | 0.59427563 |
98 | MP0000377_abnormal_hair_follicle | 0.59399516 |
99 | MP0000537_abnormal_urethra_morphology | 0.59371943 |
100 | MP0002876_abnormal_thyroid_physiology | 0.59214365 |
101 | MP0003950_abnormal_plasma_membrane | 0.58130106 |
102 | MP0002168_other_aberrant_phenotype | 0.57425388 |
103 | MP0004782_abnormal_surfactant_physiolog | 0.57320334 |
104 | MP0010678_abnormal_skin_adnexa | 0.56521443 |
105 | MP0005508_abnormal_skeleton_morphology | 0.56370650 |
106 | MP0005334_abnormal_fat_pad | 0.56157344 |
107 | MP0003453_abnormal_keratinocyte_physiol | 0.55645675 |
108 | MP0001243_abnormal_dermal_layer | 0.54021450 |
109 | MP0002928_abnormal_bile_duct | 0.50837530 |
110 | MP0002295_abnormal_pulmonary_circulatio | 0.50470442 |
111 | MP0002078_abnormal_glucose_homeostasis | 0.48882551 |
112 | MP0005266_abnormal_metabolism | 0.48252512 |
113 | MP0000604_amyloidosis | 0.47524418 |
114 | MP0000579_abnormal_nail_morphology | 0.46057743 |
115 | MP0002136_abnormal_kidney_physiology | 0.45948573 |
116 | MP0001542_abnormal_bone_strength | 0.45024632 |
117 | MP0005666_abnormal_adipose_tissue | 0.44767772 |
118 | MP0003436_decreased_susceptibility_to | 0.43282442 |
119 | MP0002796_impaired_skin_barrier | 0.43079487 |
120 | MP0002135_abnormal_kidney_morphology | 0.41524742 |
121 | MP0000767_abnormal_smooth_muscle | 0.39291212 |
122 | MP0008873_increased_physiological_sensi | 0.39178403 |
123 | MP0002282_abnormal_trachea_morphology | 0.38783426 |
124 | MP0005166_decreased_susceptibility_to | 0.38165268 |
125 | MP0005257_abnormal_intraocular_pressure | 0.38093062 |
126 | MP0009115_abnormal_fat_cell | 0.37377605 |
127 | MP0006036_abnormal_mitochondrial_physio | 0.36939043 |
128 | MP0003638_abnormal_response/metabolism_ | 0.36555092 |
129 | MP0005197_abnormal_uvea_morphology | 0.36373963 |
130 | MP0000639_abnormal_adrenal_gland | 0.34153976 |
131 | MP0005164_abnormal_response_to | 0.33838125 |
132 | MP0001915_intracranial_hemorrhage | 0.33478921 |
133 | MP0004272_abnormal_basement_membrane | 0.33415183 |
134 | MP0000163_abnormal_cartilage_morphology | 0.32928769 |
135 | MP0000249_abnormal_blood_vessel | 0.32489467 |
136 | MP0003942_abnormal_urinary_system | 0.32067588 |
137 | MP0009672_abnormal_birth_weight | 0.31945941 |
138 | MP0003566_abnormal_cell_adhesion | 0.31895208 |
139 | MP0003115_abnormal_respiratory_system | 0.31569239 |
140 | MP0000613_abnormal_salivary_gland | 0.30624628 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 7.02017272 |
2 | Deep venous thrombosis (HP:0002625) | 7.01383868 |
3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.00298172 |
4 | Intrahepatic cholestasis (HP:0001406) | 6.85074188 |
5 | Xanthomatosis (HP:0000991) | 6.33759891 |
6 | Hypobetalipoproteinemia (HP:0003563) | 6.00202453 |
7 | Prolonged partial thromboplastin time (HP:0003645) | 5.96850560 |
8 | Complement deficiency (HP:0004431) | 5.33251640 |
9 | Hyperlipoproteinemia (HP:0010980) | 5.21959454 |
10 | Hypolipoproteinemia (HP:0010981) | 4.67463429 |
11 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.56092226 |
12 | Joint hemorrhage (HP:0005261) | 4.52172722 |
13 | Hyperglycinemia (HP:0002154) | 4.37804176 |
14 | Epidermoid cyst (HP:0200040) | 4.30939838 |
15 | Hypoalphalipoproteinemia (HP:0003233) | 4.26256577 |
16 | Hyperammonemia (HP:0001987) | 4.24737153 |
17 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.20816702 |
18 | Abnormality of complement system (HP:0005339) | 4.10916319 |
19 | Abnormality of the common coagulation pathway (HP:0010990) | 4.02076438 |
20 | Hyperglycinuria (HP:0003108) | 4.02033461 |
21 | Fat malabsorption (HP:0002630) | 3.98854848 |
22 | Abnormality of methionine metabolism (HP:0010901) | 3.97306694 |
23 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.93087665 |
24 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.86353956 |
25 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.83074949 |
26 | Abnormality of glycine metabolism (HP:0010895) | 3.77581047 |
27 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.77581047 |
28 | Ketosis (HP:0001946) | 3.61154959 |
29 | Hypercholesterolemia (HP:0003124) | 3.51643732 |
30 | Abnormality of the intrinsic pathway (HP:0010989) | 3.41861940 |
31 | Hypoglycemic coma (HP:0001325) | 3.39280067 |
32 | Hemorrhage of the eye (HP:0011885) | 3.31078484 |
33 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.15417720 |
34 | Myocardial infarction (HP:0001658) | 3.13797867 |
35 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.06745220 |
36 | Conjugated hyperbilirubinemia (HP:0002908) | 3.05895482 |
37 | Steatorrhea (HP:0002570) | 3.02633533 |
38 | Hyperbilirubinemia (HP:0002904) | 3.01783926 |
39 | Abnormality of serum amino acid levels (HP:0003112) | 2.97100513 |
40 | Hepatocellular carcinoma (HP:0001402) | 2.95723180 |
41 | Abnormality of nucleobase metabolism (HP:0010932) | 2.88651810 |
42 | Vascular calcification (HP:0004934) | 2.75203941 |
43 | Back pain (HP:0003418) | 2.74933338 |
44 | Delayed CNS myelination (HP:0002188) | 2.74125049 |
45 | Systemic lupus erythematosus (HP:0002725) | 2.72991602 |
46 | Skin nodule (HP:0200036) | 2.67021623 |
47 | Cardiovascular calcification (HP:0011915) | 2.65147499 |
48 | Mitral stenosis (HP:0001718) | 2.62076533 |
49 | Malnutrition (HP:0004395) | 2.61490150 |
50 | Spontaneous abortion (HP:0005268) | 2.59181295 |
51 | Late onset (HP:0003584) | 2.53920771 |
52 | Neonatal onset (HP:0003623) | 2.49429004 |
53 | Protrusio acetabuli (HP:0003179) | 2.47202373 |
54 | Lethargy (HP:0001254) | 2.46379805 |
55 | Glomerulonephritis (HP:0000099) | 2.45971181 |
56 | Abnormality of purine metabolism (HP:0004352) | 2.41440240 |
57 | Metabolic acidosis (HP:0001942) | 2.40492176 |
58 | Bifid scrotum (HP:0000048) | 2.38653770 |
59 | Esophageal varix (HP:0002040) | 2.37178206 |
60 | Vertebral compression fractures (HP:0002953) | 2.37036115 |
61 | Menorrhagia (HP:0000132) | 2.35845654 |
62 | Spastic diplegia (HP:0001264) | 2.33318648 |
63 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.32575664 |
64 | Dicarboxylic aciduria (HP:0003215) | 2.32575664 |
65 | Abnormality of the Achilles tendon (HP:0005109) | 2.31554677 |
66 | Rickets (HP:0002748) | 2.30915094 |
67 | Ketoacidosis (HP:0001993) | 2.30824431 |
68 | Acanthosis nigricans (HP:0000956) | 2.30422221 |
69 | Peritonitis (HP:0002586) | 2.28177610 |
70 | Irritability (HP:0000737) | 2.24050499 |
71 | Abnormal cartilage morphology (HP:0002763) | 2.22849676 |
72 | Acanthocytosis (HP:0001927) | 2.17458637 |
73 | Hydroxyprolinuria (HP:0003080) | 2.13791540 |
74 | Abnormality of proline metabolism (HP:0010907) | 2.13791540 |
75 | Opisthotonus (HP:0002179) | 2.13779372 |
76 | Pancreatitis (HP:0001733) | 2.10027316 |
77 | Osteomalacia (HP:0002749) | 2.08772558 |
78 | Cerebral edema (HP:0002181) | 2.06607772 |
79 | Hypochromic microcytic anemia (HP:0004840) | 2.05942197 |
80 | Amyloidosis (HP:0011034) | 2.05449494 |
81 | Abnormal gallbladder morphology (HP:0012437) | 2.04789998 |
82 | Ulnar bowing (HP:0003031) | 2.04727402 |
83 | Hypophosphatemic rickets (HP:0004912) | 2.04722952 |
84 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.04471753 |
85 | Short nail (HP:0001799) | 2.04202531 |
86 | Cholelithiasis (HP:0001081) | 2.04001869 |
87 | Abnormal gallbladder physiology (HP:0012438) | 2.03813712 |
88 | Cholecystitis (HP:0001082) | 2.03813712 |
89 | Gout (HP:0001997) | 2.03429507 |
90 | Enlarged kidneys (HP:0000105) | 1.97699050 |
91 | Abnormal delivery (HP:0001787) | 1.96445667 |
92 | Flat acetabular roof (HP:0003180) | 1.96112058 |
93 | Arterial tortuosity (HP:0005116) | 1.94820336 |
94 | Gingival bleeding (HP:0000225) | 1.94164371 |
95 | Nephritis (HP:0000123) | 1.92230565 |
96 | Cervical subluxation (HP:0003308) | 1.91602263 |
97 | Generalized aminoaciduria (HP:0002909) | 1.91342810 |
98 | Pseudobulbar signs (HP:0002200) | 1.91132514 |
99 | Bronchomalacia (HP:0002780) | 1.90214389 |
100 | Vomiting (HP:0002013) | 1.90199941 |
101 | Hypoglycemic seizures (HP:0002173) | 1.89818692 |
102 | Reduced antithrombin III activity (HP:0001976) | 1.88462478 |
103 | Polycythemia (HP:0001901) | 1.87790860 |
104 | Brushfield spots (HP:0001088) | 1.87541280 |
105 | Vascular tortuosity (HP:0004948) | 1.87190497 |
106 | Alkalosis (HP:0001948) | 1.86721792 |
107 | Right ventricular cardiomyopathy (HP:0011663) | 1.86386855 |
108 | Hypertriglyceridemia (HP:0002155) | 1.85368506 |
109 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.84372157 |
110 | Premature rupture of membranes (HP:0001788) | 1.83912288 |
111 | Abnormality of iron homeostasis (HP:0011031) | 1.83781467 |
112 | Abnormality of carpal bone ossification (HP:0006257) | 1.83054637 |
113 | Sensorimotor neuropathy (HP:0007141) | 1.82655150 |
114 | Advanced eruption of teeth (HP:0006288) | 1.81935506 |
115 | Septate vagina (HP:0001153) | 1.80375606 |
116 | Abnormality of the gallbladder (HP:0005264) | 1.79356345 |
117 | Blue sclerae (HP:0000592) | 1.75811638 |
118 | Thrombophlebitis (HP:0004418) | 1.75612355 |
119 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.74635232 |
120 | Increased mean platelet volume (HP:0011877) | 1.73032394 |
121 | Poikilocytosis (HP:0004447) | 1.72889683 |
122 | Glycosuria (HP:0003076) | 1.72764049 |
123 | Atrophic scars (HP:0001075) | 1.72627942 |
124 | Abdominal distention (HP:0003270) | 1.71532735 |
125 | Aortic dissection (HP:0002647) | 1.71483869 |
126 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.69770320 |
127 | Osteolytic defects of the hand bones (HP:0009699) | 1.69770320 |
128 | Hypotrichosis (HP:0001006) | 1.66064547 |
129 | Focal segmental glomerulosclerosis (HP:0000097) | 1.64999142 |
130 | Abnormal tarsal ossification (HP:0008369) | 1.61258079 |
131 | Microglossia (HP:0000171) | 1.60950763 |
132 | Asymmetry of the thorax (HP:0001555) | 1.59168304 |
133 | Achilles tendon contracture (HP:0001771) | 1.59078731 |
134 | Lymphangioma (HP:0100764) | 1.58401279 |
135 | Pterygium (HP:0001059) | 1.58035079 |
136 | Reticulocytosis (HP:0001923) | 1.57840549 |
137 | Abnormality of the gastric mucosa (HP:0004295) | 1.57280149 |
138 | Ankle contracture (HP:0006466) | 1.56387125 |
139 | Cerebral aneurysm (HP:0004944) | 1.56312156 |
140 | Natal tooth (HP:0000695) | 1.54354466 |
141 | Glomerulosclerosis (HP:0000096) | 1.52717771 |
142 | Mucopolysacchariduria (HP:0008155) | 1.52636460 |
143 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.52636460 |
144 | Shallow orbits (HP:0000586) | 1.51541743 |
145 | J-shaped sella turcica (HP:0002680) | 1.51290944 |
146 | Abnormal hair laboratory examination (HP:0003328) | 1.51199489 |
147 | Fragile skin (HP:0001030) | 1.50824046 |
148 | Abnormality of vitamin metabolism (HP:0100508) | 1.49419416 |
149 | Abnormal ossification of hand bones (HP:0005921) | 1.48780842 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 5.55239557 |
2 | ERN1 | 4.44336388 |
3 | SIK1 | 3.68201403 |
4 | FGFR4 | 3.07399289 |
5 | ERBB4 | 2.86982702 |
6 | EPHA2 | 2.53724174 |
7 | MST1R | 2.43554605 |
8 | NME2 | 2.34136716 |
9 | MAPKAPK3 | 2.23113514 |
10 | TRIB3 | 2.20769746 |
11 | NEK9 | 2.19930411 |
12 | ICK | 2.00453573 |
13 | LATS1 | 1.98755547 |
14 | MAP3K3 | 1.94481864 |
15 | PKN2 | 1.90846079 |
16 | MAPK11 | 1.77205594 |
17 | SMG1 | 1.66411740 |
18 | PAK4 | 1.60485330 |
19 | INSRR | 1.59872072 |
20 | LMTK2 | 1.57944262 |
21 | EPHB2 | 1.57267418 |
22 | RPS6KB2 | 1.55102685 |
23 | MAP2K3 | 1.52122043 |
24 | ABL2 | 1.50428779 |
25 | TESK1 | 1.47525231 |
26 | STK38L | 1.45121960 |
27 | DYRK1B | 1.42608399 |
28 | EEF2K | 1.39843404 |
29 | MUSK | 1.38175547 |
30 | CDK6 | 1.37460584 |
31 | MAP3K11 | 1.34707014 |
32 | GRK6 | 1.34061977 |
33 | CDK12 | 1.33247495 |
34 | TAOK3 | 1.33072821 |
35 | FRK | 1.26689771 |
36 | KDR | 1.25786945 |
37 | TGFBR2 | 1.24783373 |
38 | PRKD2 | 1.23700227 |
39 | TAOK2 | 1.22559689 |
40 | BMX | 1.22078721 |
41 | EPHA3 | 1.19877077 |
42 | LATS2 | 1.18790882 |
43 | PTK6 | 1.16845212 |
44 | MAP2K4 | 1.16085837 |
45 | TBK1 | 1.13939528 |
46 | MAP3K10 | 1.13471823 |
47 | DDR2 | 1.11358746 |
48 | MAPK4 | 1.09146147 |
49 | PIK3CG | 1.04550955 |
50 | MET | 1.04195823 |
51 | PRKG2 | 0.98858622 |
52 | FLT3 | 0.96525566 |
53 | STK38 | 0.95505020 |
54 | MAP3K2 | 0.94583782 |
55 | MAP2K6 | 0.91243201 |
56 | TYK2 | 0.91077566 |
57 | ERBB2 | 0.90366105 |
58 | MAPK15 | 0.88504777 |
59 | PTK2 | 0.86688053 |
60 | MELK | 0.85001992 |
61 | SCYL2 | 0.83475147 |
62 | MAP3K6 | 0.83226086 |
63 | MAP2K2 | 0.82503108 |
64 | JAK2 | 0.82068407 |
65 | CSK | 0.81757822 |
66 | MYLK | 0.81506813 |
67 | PIK3CA | 0.80598271 |
68 | ILK | 0.79724786 |
69 | NTRK1 | 0.79539541 |
70 | FER | 0.79034697 |
71 | PRKAA2 | 0.78329997 |
72 | PIM1 | 0.78107756 |
73 | MAP3K7 | 0.77557329 |
74 | GSK3A | 0.77225295 |
75 | IRAK3 | 0.76929289 |
76 | RPS6KA4 | 0.76926412 |
77 | EPHB1 | 0.74726895 |
78 | CDK7 | 0.71517183 |
79 | PIM2 | 0.71108596 |
80 | ARAF | 0.69743098 |
81 | NLK | 0.68983440 |
82 | MAP3K14 | 0.68600306 |
83 | PDPK1 | 0.68530472 |
84 | IKBKE | 0.67371570 |
85 | PRKAA1 | 0.67226831 |
86 | MAPK12 | 0.65592662 |
87 | PINK1 | 0.65004829 |
88 | TTN | 0.63773136 |
89 | CAMK2G | 0.63009583 |
90 | TESK2 | 0.61904137 |
91 | RIPK1 | 0.60533875 |
92 | PDK2 | 0.60393931 |
93 | RET | 0.56891700 |
94 | CAMK1G | 0.52511254 |
95 | NEK6 | 0.52124746 |
96 | CDK8 | 0.51667213 |
97 | PDGFRA | 0.51331061 |
98 | CDK9 | 0.50750971 |
99 | SGK3 | 0.50203390 |
100 | TAOK1 | 0.50148828 |
101 | CDK4 | 0.49852558 |
102 | RPS6KA2 | 0.48677171 |
103 | MAP2K1 | 0.47862261 |
104 | IKBKB | 0.47324544 |
105 | MAPKAPK2 | 0.46772756 |
106 | PAK2 | 0.45940695 |
107 | FGFR3 | 0.43119883 |
108 | STK3 | 0.42581920 |
109 | MAP3K12 | 0.42412904 |
110 | TIE1 | 0.41403227 |
111 | PRKCZ | 0.41188540 |
112 | CSNK1G1 | 0.40817665 |
113 | IRAK1 | 0.40501845 |
114 | TLK1 | 0.40106171 |
115 | AKT3 | 0.40014617 |
116 | PRKCI | 0.39428620 |
117 | MTOR | 0.38748295 |
118 | MAP3K9 | 0.38695709 |
119 | PRKACG | 0.38667223 |
120 | PDGFRB | 0.38195521 |
121 | CAMK2B | 0.37798305 |
122 | AKT2 | 0.37178223 |
123 | JAK1 | 0.37171275 |
124 | MAPK7 | 0.36628346 |
125 | CAMK1D | 0.35841189 |
126 | SGK2 | 0.35701574 |
127 | ACVR1B | 0.35311722 |
128 | ABL1 | 0.34230255 |
129 | CHUK | 0.33753892 |
130 | PBK | 0.33586180 |
131 | CDC42BPA | 0.33271380 |
132 | LIMK1 | 0.33002585 |
133 | EIF2AK1 | 0.32906581 |
134 | PRPF4B | 0.32659854 |
135 | MAP3K1 | 0.31799677 |
136 | TRPM7 | 0.31618359 |
137 | IGF1R | 0.30556461 |
138 | PRKD1 | 0.29496997 |
139 | MAP3K5 | 0.29087386 |
140 | CAMK2D | 0.27950899 |
141 | KSR2 | 0.25360273 |
142 | RPS6KC1 | 0.24747379 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.41108127 |
2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.71626618 |
3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.20785297 |
4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.98412120 |
5 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.88674251 |
6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.87711799 |
7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.71875564 |
8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.63183656 |
9 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.57545532 |
10 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.48033188 |
11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.45612817 |
12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.45192262 |
13 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.40772688 |
14 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.37730552 |
15 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.28823510 |
16 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.28207332 |
17 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.23626904 |
18 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.14603579 |
19 | Peroxisome_Homo sapiens_hsa04146 | 1.97182123 |
20 | Retinol metabolism_Homo sapiens_hsa00830 | 1.95402150 |
21 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.88618500 |
22 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.87438455 |
23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.80373987 |
24 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.77124189 |
25 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.64029143 |
26 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.58832877 |
27 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.58728378 |
28 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.58009922 |
29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.57434977 |
30 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.56830438 |
31 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.53064544 |
32 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.52403099 |
33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.48517763 |
34 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.46062994 |
35 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.45463573 |
36 | Bile secretion_Homo sapiens_hsa04976 | 1.43885690 |
37 | Sulfur relay system_Homo sapiens_hsa04122 | 1.39289987 |
38 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.29823357 |
39 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.27849659 |
40 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.24792866 |
41 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.24332490 |
42 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.21228923 |
43 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.21158106 |
44 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.19711572 |
45 | ABC transporters_Homo sapiens_hsa02010 | 1.09093405 |
46 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.07608442 |
47 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.07320915 |
48 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.05724948 |
49 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.04824845 |
50 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.03288106 |
51 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.02355935 |
52 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.00123450 |
53 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.98018262 |
54 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.95120075 |
55 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.95055086 |
56 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.94248242 |
57 | Carbon metabolism_Homo sapiens_hsa01200 | 0.93927942 |
58 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.86503433 |
59 | Lysine degradation_Homo sapiens_hsa00310 | 0.70091281 |
60 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.67805025 |
61 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.67678097 |
62 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.66894153 |
63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.64082200 |
64 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.61424823 |
65 | Galactose metabolism_Homo sapiens_hsa00052 | 0.50310735 |
66 | Prion diseases_Homo sapiens_hsa05020 | 0.47179900 |
67 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.47168251 |
68 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45368688 |
69 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.44462025 |
70 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.34100520 |
71 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.33610475 |
72 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.25535645 |
73 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.23705857 |
74 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.21284063 |
75 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.20702224 |
76 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.19753934 |
77 | Other glycan degradation_Homo sapiens_hsa00511 | 0.18371718 |
78 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.17418715 |
79 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.17115447 |
80 | Insulin resistance_Homo sapiens_hsa04931 | 0.16562959 |
81 | Focal adhesion_Homo sapiens_hsa04510 | 0.14968605 |
82 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.13799016 |
83 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.12952016 |
84 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.12641521 |
85 | Thyroid cancer_Homo sapiens_hsa05216 | 0.12229133 |
86 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.09390521 |
87 | Bladder cancer_Homo sapiens_hsa05219 | 0.08197825 |
88 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.08153698 |
89 | Adherens junction_Homo sapiens_hsa04520 | 0.07993648 |
90 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.07528573 |
91 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.07406625 |
92 | Tight junction_Homo sapiens_hsa04530 | 0.06361745 |
93 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.05009046 |
94 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.04650643 |
95 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.04526448 |
96 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.03503311 |
97 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1514715 |
98 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1455431 |
99 | Hepatitis C_Homo sapiens_hsa05160 | -0.1428356 |
100 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | -0.1405008 |
101 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1325528 |
102 | Malaria_Homo sapiens_hsa05144 | -0.1154992 |
103 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1130217 |
104 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.0829175 |
105 | ECM-receptor interaction_Homo sapiens_hsa04512 | -0.0809318 |
106 | Amoebiasis_Homo sapiens_hsa05146 | -0.0768581 |
107 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | -0.0737693 |
108 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0674947 |
109 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0607000 |
110 | Basal cell carcinoma_Homo sapiens_hsa05217 | -0.0408346 |
111 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.0333248 |
112 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0266204 |
113 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0217317 |
114 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0150393 |
115 | Mineral absorption_Homo sapiens_hsa04978 | -0.0129342 |
116 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.0068297 |